Download Library

Date Title Documents

Anthera Corporate Presentation

Additional Definitive Proxy Materials

Form 10-K

EULAR 2015 Effects of Blisibimod, an Inhibitor of B Cell Activating Factor, on Patient-Reported Outcomes and Disease Activity in Patients with SLE

Definitive Additional Proxy Materials

Proxy Statement

Effects of Blisibimod on Patient Reported Outcomes in Patients with SLE - ACR 2014

Anthera Corporate Update

Effects Of Blisibimod On Serum Immunoglobulins and Infection Risk - 2013 ACR Presentation

Effects of Chronic Treatment with Sub-cutaneous Blisibimod on Renal and Inflammation Biomarkers - PANLAR 2014